These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 10480584

  • 1. Comparative study of extended release albuterol sulfate and long-acting inhaled salmeterol xinafoate in the treatment of nocturnal asthma.
    Martin RJ, Kraft M, Beaucher WN, Kiechel F, Sublett JL, LaVallee N, Shilstone J.
    Ann Allergy Asthma Immunol; 1999 Aug; 83(2):121-6. PubMed ID: 10480584
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
    Maspero J, Guerra F, Cuevas F, Gutierrez JP, Soto-Ramos M, Anderton S, Mechali D, Chan R, Pedersen S.
    Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
    [Abstract] [Full Text] [Related]

  • 3. [Salmeterol improves the control of disease in patients with moderate asthma. A comparative study of inhaled salmeterol 50 mg and salbutamol depot tablets 8 mg, both administered twice daily].
    Ringbaek TJ, Søes-Petersen U, Christensen M, Iversen ET, Rasmussen FV.
    Ugeskr Laeger; 1996 Jul 01; 158(27):3940-3. PubMed ID: 8701511
    [Abstract] [Full Text] [Related]

  • 4. A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma.
    Pearlman DS, Chervinsky P, LaForce C, Seltzer JM, Southern DL, Kemp JP, Dockhorn RJ, Grossman J, Liddle RF, Yancey SW.
    N Engl J Med; 1992 Nov 12; 327(20):1420-5. PubMed ID: 1357554
    [Abstract] [Full Text] [Related]

  • 5. Initial treatment of symptomatic mild to moderate bronchial asthma with the salmeterol/fluticasone propionate (50/250 microg) combination product (SAS 40023).
    Baumgarten C, Geldszus R, Behre U, Peslis N, Trautmann M, Viani-Initial Study Group.
    Eur J Med Res; 2002 Jan 29; 7(1):1-7. PubMed ID: 11827834
    [Abstract] [Full Text] [Related]

  • 6. [Therapy of nocturnal asthma: salmeterol versus nocturnal administration of retard theophylline--comparison of effectiveness and tolerance].
    Ukena D, Koper I, Braun H, Leutz M, Schlimmer P, Sybrecht GW.
    Pneumologie; 1997 Mar 29; 51(3):317-23. PubMed ID: 9173422
    [Abstract] [Full Text] [Related]

  • 7. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
    Cowie RL, Boulet LP, Keith PK, Scott-Wilson CA, House KW, Dorinsky PM.
    Clin Ther; 2007 Jul 29; 29(7):1390-402. PubMed ID: 17825690
    [Abstract] [Full Text] [Related]

  • 8. Salmeterol xinafoate in children on high dose inhaled steroids.
    Russell G, Williams DA, Weller P, Price JF.
    Ann Allergy Asthma Immunol; 1995 Nov 29; 75(5):423-8. PubMed ID: 7583864
    [Abstract] [Full Text] [Related]

  • 9. Salmeterol versus theophylline in the treatment of asthma.
    Pollard SJ, Spector SL, Yancey SW, Cox FM, Emmett A.
    Ann Allergy Asthma Immunol; 1997 May 29; 78(5):457-64. PubMed ID: 9164358
    [Abstract] [Full Text] [Related]

  • 10. Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists.
    Murray J, Rosenthal R, Somerville L, Blake K, House K, Baitinger L, VanderMeer A, Dorinsky P.
    Ann Allergy Asthma Immunol; 2004 Oct 29; 93(4):351-9. PubMed ID: 15521371
    [Abstract] [Full Text] [Related]

  • 11. Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma.
    D'Alonzo GE, Nathan RA, Henochowicz S, Morris RJ, Ratner P, Rennard SI.
    JAMA; 1994 May 11; 271(18):1412-6. PubMed ID: 7909853
    [Abstract] [Full Text] [Related]

  • 12. Effectiveness and tolerability of high-dose salmeterol in cystic fibrosis.
    Hordvik NL, Sammut PH, Judy CG, Colombo JL.
    Pediatr Pulmonol; 2002 Oct 11; 34(4):287-96. PubMed ID: 12205570
    [Abstract] [Full Text] [Related]

  • 13. Addition of montelukast or salmeterol to fluticasone for protection against asthma attacks: a randomized, double-blind, multicenter study.
    Ilowite J, Webb R, Friedman B, Kerwin E, Bird SR, Hustad CM, Edelman JM.
    Ann Allergy Asthma Immunol; 2004 Jun 11; 92(6):641-8. PubMed ID: 15237766
    [Abstract] [Full Text] [Related]

  • 14. Long-acting beta 2-agonist salmeterol compared with albuterol in maintenance asthma therapy.
    Pearlman DS.
    Ann Allergy Asthma Immunol; 1995 Aug 11; 75(2):180-4. PubMed ID: 7648385
    [Abstract] [Full Text] [Related]

  • 15. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
    Bjermer L, Bisgaard H, Bousquet J, Fabbri LM, Greening A, Haahtela T, Holgate ST, Picado C, Leff JA.
    Respir Med; 2000 Jun 11; 94(6):612-21. PubMed ID: 10921768
    [Abstract] [Full Text] [Related]

  • 16. Fluticasone propionate/salmeterol combination compared with montelukast for the treatment of persistent asthma.
    Pearlman DS, White MV, Lieberman AK, Pepsin PJ, Kalberg C, Emmett A, Bowers B, Rickard KA, Dorinsky P.
    Ann Allergy Asthma Immunol; 2002 Feb 11; 88(2):227-35. PubMed ID: 11868930
    [Abstract] [Full Text] [Related]

  • 17. Comparison of oral bambuterol and inhaled salmeterol in patients with symptomatic asthma and using inhaled corticosteroids.
    Crompton GK, Ayres JG, Basran G, Schiraldi G, Brusasco V, Eivindson A, Jamieson AH, Olsson H.
    Am J Respir Crit Care Med; 1999 Mar 11; 159(3):824-8. PubMed ID: 10051257
    [Abstract] [Full Text] [Related]

  • 18. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
    Pearlman DS, Stricker W, Weinstein S, Gross G, Chervinsky P, Woodring A, Prillaman B, Shah T.
    Ann Allergy Asthma Immunol; 1999 Mar 11; 82(3):257-65. PubMed ID: 10094216
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.